Related Experiment Video

Updated: Jul 10, 2026

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
06:21

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model

Published on: May 27, 2016

What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies

Peg Esper1, Danielle Gale, Paula Muehlbauer

  • 1University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. pesper@umich.edu

Clinical Journal of Oncology Nursing
|October 27, 2007
PubMed

Insights

New targeted cancer therapies offer benefits but cause unique skin toxicities. This review examines managing these dermatologic reactions, highlighting the need for more research into effective treatments.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Numerous novel targeted therapies are now standard in oncology.
  • These advanced treatments, including small-molecule inhibitors and monoclonal antibodies, present unique toxicities.
  • Dermatologic reactions are a common side effect of these new agents.

Purpose of the Study:

  • To review the current literature on dermatologic toxicities associated with newer targeted cancer therapies.
  • To provide evidence-based recommendations for managing these cutaneous side effects.
  • To identify gaps in knowledge and areas for future research.

Main Methods:

  • Comprehensive literature search of scientific evidence on dermatologic toxicities.
  • Analysis of data from clinical trials and postmarketing surveillance.
  • Synthesis of current management strategies for targeted therapy-induced rashes.

Main Results:

  • Targeted therapies, particularly small-molecule inhibitors and monoclonal antibodies, induce a spectrum of unique dermatologic reactions.
  • Management recommendations are primarily based on clinical trial data and postmarketing experience.
  • Limited scientific literature exists detailing specific treatment methodologies for these toxicities.

Conclusions:

  • Dermatologic toxicities are a significant concern with novel targeted cancer agents.
  • Current management strategies require further validation through additional research.
  • Elucidating optimal treatment protocols is crucial for improving patient care and adherence to therapy.

More Related Videos

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...